88 related articles for article (PubMed ID: 17510312)
21. Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significance.
Lee ES; Issa JP; Roberts DB; Williams MD; Weber RS; Kies MS; El-Naggar AK
Clin Cancer Res; 2008 May; 14(9):2664-72. PubMed ID: 18451230
[TBL] [Abstract][Full Text] [Related]
22. Aberrant methylation of the p16 gene is frequently detected in advanced colorectal cancer.
Goto T; Mizukami H; Shirahata A; Sakata M; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y; Hibi K
Anticancer Res; 2009 Jan; 29(1):275-7. PubMed ID: 19331161
[TBL] [Abstract][Full Text] [Related]
23. Vimentin methylation as a marker for advanced colorectal carcinoma.
Shirahata A; Sakata M; Sakuraba K; Goto T; Mizukami H; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y; Hibi K
Anticancer Res; 2009 Jan; 29(1):279-81. PubMed ID: 19331162
[TBL] [Abstract][Full Text] [Related]
24. Promoter hypermethylation-mediated inactivation of LRRC4 in gliomas.
Zhang Z; Li D; Wu M; Xiang B; Wang L; Zhou M; Chen P; Li X; Shen S; Li G
BMC Mol Biol; 2008 Nov; 9():99. PubMed ID: 18976507
[TBL] [Abstract][Full Text] [Related]
25. Promoter methylation of the Wnt/beta-catenin signaling antagonist Dkk-3 is associated with poor survival in gastric cancer.
Yu J; Tao Q; Cheng YY; Lee KY; Ng SS; Cheung KF; Tian L; Rha SY; Neumann U; Röcken C; Ebert MP; Chan FK; Sung JJ
Cancer; 2009 Jan; 115(1):49-60. PubMed ID: 19051296
[TBL] [Abstract][Full Text] [Related]
26. A novel real-time PCR assay for quantitative analysis of methylated alleles (QAMA): analysis of the retinoblastoma locus.
Zeschnigk M; Böhringer S; Price EA; Onadim Z; Masshöfer L; Lohmann DR
Nucleic Acids Res; 2004 Sep; 32(16):e125. PubMed ID: 15353561
[TBL] [Abstract][Full Text] [Related]
27. LINE-1 hypomethylation during primary colon cancer progression.
Sunami E; de Maat M; Vu A; Turner RR; Hoon DS
PLoS One; 2011 Apr; 6(4):e18884. PubMed ID: 21533144
[TBL] [Abstract][Full Text] [Related]
28. MethyLight droplet digital PCR for detection and absolute quantification of infrequently methylated alleles.
Yu M; Carter KT; Makar KW; Vickers K; Ulrich CM; Schoen RE; Brenner D; Markowitz SD; Grady WM
Epigenetics; 2015; 10(9):803-9. PubMed ID: 26186366
[TBL] [Abstract][Full Text] [Related]
29. Methylation of TFPI2 no longer detected in the serum DNA of colorectal cancer patients after curative surgery.
Hibi K; Goto T; Shirahata A; Saito M; Kigawa G; Nemoto H; Sanada Y
Anticancer Res; 2012 Mar; 32(3):787-90. PubMed ID: 22399594
[TBL] [Abstract][Full Text] [Related]
30. Highly-methylated colorectal cancers show poorly-differentiated phenotype.
Hibi K; Nakao A
Anticancer Res; 2006; 26(6B):4263-6. PubMed ID: 17201142
[TBL] [Abstract][Full Text] [Related]
31. A new method for accurate assessment of DNA quality after bisulfite treatment.
Ehrich M; Zoll S; Sur S; van den Boom D
Nucleic Acids Res; 2007; 35(5):e29. PubMed ID: 17259213
[TBL] [Abstract][Full Text] [Related]
32. High quality assessment of DNA methylation in archival tissues from colorectal cancer patients using quantitative high-resolution melting analysis.
Balic M; Pichler M; Strutz J; Heitzer E; Ausch C; Samonigg H; Cote RJ; Dandachi N
J Mol Diagn; 2009 Mar; 11(2):102-8. PubMed ID: 19179456
[TBL] [Abstract][Full Text] [Related]
33. The role of deoxyribonucleic acid methylation in development, diagnosis, and prognosis of bladder cancer.
Gonzalgo ML; Datar RH; Schoenberg MP; Cote RJ
Urol Oncol; 2007; 25(3):228-35. PubMed ID: 17483020
[TBL] [Abstract][Full Text] [Related]
34. DNA hypermethylation in colorectal neoplasms and inflammatory bowel disease: a mini review.
Maeda O; Ando T; Watanabe O; Ishiguro K; Ohmiya N; Niwa Y; Goto H
Inflammopharmacology; 2006 Dec; 14(5-6):204-6. PubMed ID: 17093903
[TBL] [Abstract][Full Text] [Related]
35. Promoter methylation, transcription, and retrotransposition of LINE-1 in colorectal adenomas and adenocarcinomas.
Shademan M; Zare K; Zahedi M; Mosannen Mozaffari H; Bagheri Hosseini H; Ghaffarzadegan K; Goshayeshi L; Dehghani H
Cancer Cell Int; 2020; 20():426. PubMed ID: 32905102
[TBL] [Abstract][Full Text] [Related]
36. Quantification of the sixth DNA base 5-hydroxymethylcytosine in colorectal cancer tissue and C-26 cell line.
Zhang LT; Zhang LJ; Zhang JJ; Ye XX; Xie AM; Chen LY; Kang JX; Cai C
Bioanalysis; 2013 Apr; 5(7):839-45. PubMed ID: 23534428
[TBL] [Abstract][Full Text] [Related]
37. Genomic determinants of prognosis in colorectal cancer.
Vendrell E; Morales C; Risques RA; Capellà G; Peinado MA
Cancer Lett; 2005 Apr; 221(1):1-9. PubMed ID: 15797621
[TBL] [Abstract][Full Text] [Related]
38. Impact of sample heterogeneity on methylation analysis.
Loh M; Liem N; Lim PL; Vaithilingam A; Cheng CL; Salto-Tellez M; Yong WP; Soong R
Diagn Mol Pathol; 2010 Dec; 19(4):243-7. PubMed ID: 21051995
[TBL] [Abstract][Full Text] [Related]
39. Preface: colorectal cancer.
Bresalier RS
Cancer Metastasis Rev; 2004; 23(1-2):7-9. PubMed ID: 15000145
[No Abstract] [Full Text] [Related]
40. Blood free-circulating DNA testing by highly sensitive methylation assay to diagnose colorectal neoplasias.
Suehiro Y; Hashimoto S; Higaki S; Fujii I; Suzuki C; Hoshida T; Matsumoto T; Yamaoka Y; Takami T; Sakaida I; Yamasaki T
Oncotarget; 2018 Mar; 9(24):16974-16987. PubMed ID: 29682198
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
